Financhill
Back

Rocket Pharmaceuticals Quote, Financials, Valuation and Earnings

Buy
60

RCKT
Rocket Pharmaceuticals

Last Price:
23.41
Seasonality Move:
17.22%

7 Day Trial

ALL ACCESS PASS

$ 7

Rocket Pharmaceuticals Price Quote

$23.41
-0.25 (-1.06%)
(Updated: May 16, 2024 at 6:55 PM ET)

Rocket Pharmaceuticals Key Stats

Buy
60
Rocket Pharmaceuticals (RCKT) is a Buy

Day range:
$23.53 - $24.46
52-week range:
$14.89 - $32.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
4.87%

Volume:
418.2K
Avg. volume:
643.4K
1-year change:
8.68%
Market cap:
$2.1B
Revenue:
$0
EPS:
$-2.87

How Much Does Rocket Pharmaceuticals Make?

Data Unavailable

Is Rocket Pharmaceuticals Growing As A Company?

Data Unavailable

Rocket Pharmaceuticals Stock Price Performance

What Is Rocket Pharmaceuticals 52-Week High & Low?

Rocket Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Rocket Pharmaceuticals?

Is Rocket Pharmaceuticals Cash Flow Positive?

  • What Is RCKT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$194.2M
  • What Is Rocket Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $191.2M
  • What Is Rocket Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$26.3M

Rocket Pharmaceuticals Return On Invested Capital

Data Unavailable

Rocket Pharmaceuticals Earnings Date & Stock Price

Rocket Pharmaceuticals Competitors

Rocket Pharmaceuticals Dividend Yield

Data Unavailable

Rocket Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 1.9%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 50.08
Upside from Last Price: 111.65%

Major Shareholders

  • How many RCKT shares are owned by institutional investors?
    123.5M RCKT shares are owned by institutional investors
  • How many RCKT shares are owned by insiders?
    1.4M RCKT shares are owned by insiders